Tony Woolard

722 total citations
4 papers, 104 citations indexed

About

Tony Woolard is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Tony Woolard has authored 4 papers receiving a total of 104 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 0 papers in Infectious Diseases. Recurrent topics in Tony Woolard's work include Pulmonary Hypertension Research and Treatments (3 papers), Protein Tyrosine Phosphatases (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Tony Woolard is often cited by papers focused on Pulmonary Hypertension Research and Treatments (3 papers), Protein Tyrosine Phosphatases (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). Tony Woolard collaborates with scholars based in United States and Greece. Tony Woolard's co-authors include Demosthenes Bouros, Αrgyris Τzouvelekis, Τheodoros Karampitsakos, Jose D. Herazo‐Maya, Guoying Yu, Patty J. Lee, Erica L. Herzog, Naftali Kaminski, Rong Wang and Yi Zhang and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine and European Journal of Pharmacology.

In The Last Decade

Tony Woolard

4 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tony Woolard United States	3	85	22	21	13	11	4	104
Gabrielle Y. Liu United States	4	130 1.5×	23 1.0×	54 2.6×	10 0.8×	4 0.4×	7	151
Thomas Le Gallou France	4	37 0.4×	23 1.0×	23 1.1×	10 0.8×	23 2.1×	10	63
Zheng Yan China	3	54 0.6×	25 1.1×	7 0.3×	3 0.2×	3 0.3×	4	82
T Wallis United Kingdom	6	66 0.8×	11 0.5×	17 0.8×	9 0.7×	3 0.3×	8	91
Gaffari Tunç Türkiye	5	26 0.3×	20 0.9×	8 0.4×	4 0.3×	4 0.4×	21	72
Maria Kallieri Greece	4	63 0.7×	6 0.3×	62 3.0×	13 1.0×	3 0.3×	22	84
C. Fernández-Díaz Spain	4	23 0.3×	9 0.4×	15 0.7×	5 0.4×	27 2.5×	8	56
Joanne Laycock United Kingdom	2	13 0.2×	19 0.9×	7 0.3×	14 1.1×	13 1.2×	3	82
Junya Matsumura Japan	4	29 0.3×	14 0.6×	10 0.5×	11 0.8×	5 0.5×	11	99
Heidi Schaarschmidt Germany	2	29 0.3×	9 0.4×	30 1.4×	6 0.5×	4 0.4×	2	46

Countries citing papers authored by Tony Woolard

Since Specialization

Citations

This map shows the geographic impact of Tony Woolard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Woolard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Woolard more than expected).

Fields of papers citing papers by Tony Woolard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Woolard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Woolard. The network helps show where Tony Woolard may publish in the future.

Co-authorship network of co-authors of Tony Woolard

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Woolard. A scholar is included among the top collaborators of Tony Woolard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Woolard. Tony Woolard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Tzouvelekis, Argyrios, Guoying Yu, Christian L. Lino Cardenas, et al.. (2016). SH2 Domain–Containing Phosphatase-2 Is a Novel Antifibrotic Regulator in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 195(4). 500–514. 41 indexed citations

2.

Karampitsakos, Τheodoros, Tony Woolard, Demosthenes Bouros, & Αrgyris Τzouvelekis. (2016). Toll-like receptors in the pathogenesis of pulmonary fibrosis. European Journal of Pharmacology. 808. 35–43. 59 indexed citations

3.

Tzouvelekis, Argyris, Guoying Yu, Jose D. Herazo‐Maya, et al.. (2016). Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells. PA780–PA780. 1 indexed citations

4.

Tzouvelekis, Argyris, Guoying Yu, Jose D. Herazo‐Maya, et al.. (2016). SH2 domain-containing phosphatase-SHP-2 is a novel anti-fibrotic regulator in pulmonary fibrosis. OA4979–OA4979. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact